Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Women biopharma executives
Pharma
Argenx banks on Vyvgart prefilled syringe approval in 2025: exec
Simpler administration of argenx's FcRn inhibitor Vyvgart will form a key part of the immunology drugmaker's expansion plans moving forward.
Fraiser Kansteiner
Feb 19, 2025 1:36pm
For CDMOs, employment and funding hitches persist after pandemic
Jan 8, 2024 10:52am
Genentech elevates interim CEO to full-time leadership position
Dec 12, 2023 4:12pm
Novartis cuts CCO title as international chief leaves
Sep 6, 2023 10:25am
Merck KGaA's contract manufacturing arm logs sharp sales decline
Aug 3, 2023 10:35am
Argenx's Vyvgart triumphs in rare neuromuscular disease study
Jul 17, 2023 10:55am
